There are 108 resources available
ESMO Presidential address
Presenter: Solange Peters
Session: ESMO Virtual Congress 2020 Opening ceremony
Resources:
Webcast
COVID-19: Public health and scientific challenges
Presenter: Anthony Fauci
Session: ESMO Virtual Congress 2020 Opening ceremony
Resources:
Slides
Webcast
Highlights of the Science weekend
Presenter: John Haanen
Session: ESMO Virtual Congress 2020 Opening ceremony
Resources:
Slides
Webcast
How T cells induce cancer regressions
Presenter: Antoni Ribas
Session: ESMO Virtual Congress 2020 Opening ceremony
Resources:
Slides
Webcast
LBA28 - A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial
Presenter: Mansoor Raza Mirza
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
806O - Radical hysterectomy in cervical cancer patients with intraoperatively detected positive lymph node: ABRAX multicentric retrospective cohort study (ENGOT-Cx3/CEEGOG CX2)
Presenter: David Cibula
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA29 - Individualized starting dose of niraparib in Chinese patients with platinum-sensitive recurrent ovarian cancer (PSROC): A randomized, double-blind, placebo-controlled, phase III trial (NORA)
Presenter: Xiaohua Wu
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA30 - INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
Presenter: Nicoletta Colombo
Session: Proffered Paper - Gynaecological cancers 1
Resources:
Abstract
Slides
Webcast
LBA39 - 3-years follow-up of double-blind randomized phase II comparing concurrent high-dose cisplatin chemo-radiation plus xevinapant or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck
Presenter: Jean Bourhis
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast
LBA40 - Neoadjuvant nivolumab and nivolumab plus ipilimumab induce (near-) complete responses in patients with head and neck squamous cell carcinoma: The IMCISION trial
Presenter: Lotje Zuur
Session: Proffered Paper - Head & Neck cancer
Resources:
Abstract
Slides
Webcast